Tumor Microenvironment
A section of Cancers (ISSN 2072-6694).
Section Information
The MDPI journal Cancers has recently defined the scope and have introduced a Tumor Microenvironment Section. The TME section aims to publish high-quality research on the molecular and cellular components of cancer microenvironment, with a particular focus on basic, translational and clinical research that has significant implications for the diagnosis, prevention and treatment of human malignancies. The subject area include, but not limited to, the mechanisms playing essential role in tumor cell plasticity under the influence of unique microenvironment, molecular and cellular markers for diagnosis, prognosis, drug targets in malignant cells and its microenvironment, and the role of microbiome in influencing the etiology and characteristics of cancer cell. The section also encourages communication of scientific advancement in complementary and alternative medicines influencing tumor microenvironment.
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Neurofibromatosis Type 1 (NF1) Related Tumors (Deadline: 1 October 2023)
- The Role of RNAs in Cancers (Deadline: 1 October 2023)
- Spatio-Temporal Changes in the Tumor Microenvironment: Focus on Hypoxia, Acidosis and Metabolism (Deadline: 1 October 2023)
- The Role of Cancer Stem Cells in Cancer Targeted Therapy (Deadline: 10 October 2023)
- Complex Approaches to Modeling the Tumor Microenvironment (Deadline: 15 October 2023)
- 2nd Edition: Colorectal Cancers (Deadline: 20 October 2023)
- The Role of Immunity in the Tumor Microenvironment (Deadline: 23 October 2023)
- The Development of Effective Therapy Targeting the Microenvironment of Cancer (Deadline: 25 October 2023)
- Targeting the Sphingolipid Metabolic Pathway: Promotion from Benchwarmer to the Starting Lineup—a Themed Issue in Memory of Dr’s. Lina Obeid and Mark Kester (Deadline: 31 October 2023)
- Cancer Cell Communications, Metastasis, and Survival in Host Microenvironment (Deadline: 31 October 2023)
- Diversity and Biology of Cancer-Associated Fibroblasts and the Novel Targeting Therapy (Deadline: 31 October 2023)
- Immune Microenvironment in Pancreatic Ductal Adenocarcinoma: Scrutinizing the Soldiers and the Weapons in the Tumor Milieu (Deadline: 31 October 2023)
- Cancer Neuroscience (Deadline: 31 October 2023)
- Advances in Integrins in Cancer (Deadline: 31 October 2023)
- Personalized Medicine—Guided Synthetic Lethality Targeting DNA Repair Pathways (Deadline: 31 October 2023)
- Endothelial Cells in Inflammation, Tissue Repair, Ageing and Cancer (Deadline: 31 October 2023)
- Targeting the JAK–STAT Signaling Axis in Cancer (Deadline: 10 November 2023)
- Proteomic and Genomic Profiling of Pancreatic Cancer (Deadline: 13 November 2023)
- The Signal-Processing in Tumor (Deadline: 15 November 2023)
- Study on the Complex Melanoma Volume II (Deadline: 15 November 2023)
- Integrins and Tumor Microenvironment, New Perspectives in Targeted Treatments (Deadline: 15 November 2023)
- Tumor-Initiating Cells in Breast Cancer: From Bench to Bedside (Deadline: 27 November 2023)
- Regulation of HIFs in Cancer Cells (Deadline: 30 November 2023)
- CAR-T Cells: Past, Present, and Future (Deadline: 30 November 2023)
- Thromboembolism in Breast Cancer: Evidence in Context (Deadline: 30 November 2023)
- The Tumor Microenvironment and Immunotherapy of Head and Neck Cancer (Deadline: 30 November 2023)
- Novel Insights into the Hallmarks of Breast Cancer Progression (Deadline: 1 December 2023)
- Microenvironment of Leukemia (Deadline: 1 December 2023)
- Acute Myeloid Leukemia: The Future Is Bright (Deadline: 5 December 2023)
- Oxidative Stress and Cancer: Possible Beneficial and Antioxidant Strategies (Deadline: 15 December 2023)
- Brain Tumor: Recent Advances and Challenges (Deadline: 15 December 2023)
- Ovarian Cancer Stem Cells and Tumor Microenvironment (Deadline: 15 December 2023)
- The Tumor Microenvironment and Its Role in Tumor Growth and Angiogenesis (Deadline: 15 December 2023)
- The Role of Hypoxia in Cancer Progression, Angiogenesis, Metastasis and Resistance to Therapy (Deadline: 15 December 2023)
- State-of-the-Art Strategies for Non-coding RNA Function Detection and Regulation in Cancer (Deadline: 15 December 2023)
- The Role of the Advanced Patient Derived Models in Tumors and Translational Medicine (Deadline: 20 December 2023)
- Tumor Microenvironment and Melanoma Therapy (Deadline: 20 December 2023)
- Autophagy–EMT Interrelations: At the Core of Tumor Transformation (Deadline: 20 December 2023)
- Invasion in Glioblastoma (Deadline: 20 December 2023)
- Tumor Immune Microenvironment in Gastric Cancers (Deadline: 25 December 2023)
- Treatment of Peripheral T-Cell Lymphomas (Deadline: 30 December 2023)
- Targeting the Tumor Microenvironment Volume II (Deadline: 31 December 2023)
- Fibroblasts and Growth Factors in Cancer (Deadline: 31 December 2023)
- Tumor Microenvironment: Intercellular Communication (Deadline: 31 December 2023)
- Cancer Metabolomic Analysis (Deadline: 31 December 2023)
- Tumor Microenvironment and Treatment in Uveal Melanoma (Deadline: 31 December 2023)
- The Role of Cancer-Associated Fibroblasts in Cancer (Deadline: 31 December 2023)
- Invasive Skin Cancers and Underlying Compartments Interactions (Deadline: 31 December 2023)
- Gene Expression Studies in Cancer Research (Deadline: 31 December 2023)
- Signaling Pathways of Breast Cancer (Deadline: 31 December 2023)
- Multi-Faceted Epigenetic Dysregulation in Acute Myeloid Leukemia (Deadline: 31 December 2023)
- Targeting Histone Deacetylases in Cancers (Deadline: 31 December 2023)
- New Insights into the Role of Tumor Microenvironment in Thoracic Cancers (Deadline: 31 December 2023)
- Tumor Markers in Lung Cancer: Current Progress, Role in Targeted Therapy and Further Direction (Deadline: 4 January 2024)
- Cancer Metabolic Landscapes and Interactions (Deadline: 20 January 2024)
- Targeting Solid Tumors and the Microenvironment with Novel Immunotherapies (Deadline: 30 January 2024)
- Advances in Plasma Cell Dyscrasias (Deadline: 31 January 2024)
- Management of Relapsed and Refractory Lymphomas (Deadline: 31 January 2024)
- Non-coding RNAs and Extracellular Vesicles in Cancer Crosstalk: Diagnostic and Therapeutic Implications (Deadline: 31 January 2024)
- Aging and Cancers (Deadline: 31 January 2024)
- Advances in Cancer Cachexia (Deadline: 31 January 2024)
- Lynch Syndrome: State of the Art (Deadline: 1 February 2024)
- Hippo Signaling in Cancer (Deadline: 20 February 2024)
- The Warburg Effect in Cancers (Deadline: 28 February 2024)
- Role of Mitochondria in Cancer: Past, Present and Future (Deadline: 29 February 2024)
- Targeting Angiogenic Pathways and Combination Approaches (Deadline: 29 February 2024)
- Understanding Hodgkin’s Lymphoma: The Role of Tumour Cells and Immune Microenvironment (Deadline: 29 February 2024)
- Adaptation Strategies of Circulating Tumor Cells (Deadline: 29 February 2024)
- The Role of Autophagy in Brain Tumors (Volume II) (Deadline: 1 March 2024)
- Functional Neuro-Oncology—Volume II (Deadline: 15 March 2024)
- Recent Perspectives on Mechanisms of Radiation-Mediated DNA Damage Induction and Response in Cancers (Deadline: 31 March 2024)
- Targeting Signal Transduction Pathways in Cancer (Deadline: 31 March 2024)
- Heat Shock Proteins in Cancers (Deadline: 31 March 2024)
- Cytokines in Cancer Immunotherapy 2.0 (Deadline: 1 April 2024)
- Tumor-Associated Microenvironments and Inflammation (Deadline: 15 April 2024)
- Emerging Therapeutic Approaches for Gastrointestinal Malignancies and the Tumour Microenvironment (Deadline: 30 April 2024)
- Post-transcriptional Regulation of Cancer-Related Processes (Deadline: 30 April 2024)
- The Extracellular Matrix in Cancer Ecosystems: Functional Contributions and Targeting Opportunities (Deadline: 30 April 2024)
- Circulating Tumor Cells (CTCs): Current and Emerging Utility in Cancer (Deadline: 30 April 2024)
- Revolutionizing Cancer Therapy: Unleashing the Power of MET Inhibitors (Deadline: 30 April 2024)
- Cell Death in Gynecologic Cancers (Deadline: 30 April 2024)
- Molecular Aspects of Tumor Microenvironment of Acute Myeloid Leukemia (Deadline: 1 May 2024)
- Microbiomes and Modulation of Therapeutic Responses in Cancer (Deadline: 15 May 2024)
- Advances in Head and Neck Cancer Research (Deadline: 20 May 2024)
- Tumor Microenvironment of Breast Cancer (Deadline: 25 May 2024)
- Tumor Microenvironment and Treatment Resistance (Deadline: 31 May 2024)
- Seminal Discoveries Relating to Chromatin Remodeling and Its Regulation of Cancer Biology (Deadline: 31 May 2024)
- Pathway in Breast Cancer (Deadline: 31 May 2024)
- Emerging Role of Exosomes in Comorbidity-Associated Cancer Progression (Deadline: 31 May 2024)
- Tumor Microenvironment in Primary Liver Cancer (Deadline: 28 June 2024)
- Circulating Tumor Cells: Origin, Fate, and Roles in Immune Evasion and Metastasis (Deadline: 30 June 2024)
- Inflammation and Metabolism of Cancers (Deadline: 30 June 2024)
- The Role of Tumor Microenvironment in Solid Tumors: Development of Cancer Research (Deadline: 30 June 2024)
- Targeting TGF-β as a Marker and Pharmacological Target against Cancer (Deadline: 15 July 2024)
- EVs and EPS in Cancer: Cell-to-Cell Communication, Diagnosis, and Evaluation of Cancer Therapy Response (Deadline: 15 July 2024)
- Inhibitors in Chronic Myeloid Leukemia (Deadline: 16 July 2024)
- Targeting Tumor Microenvironment in Cancer: Promises and Challenges (Deadline: 20 July 2024)
- Novel Therapeutic Targets for Ovarian Cancer (Deadline: 31 July 2024)
- Insights into Cancer Stem Cells (Deadline: 31 July 2024)
- Targeted Therapies for Cancer Metastasis (Deadline: 5 August 2024)
- Effects of Radiotherapy on the Tumor Microenvironment (Deadline: 15 August 2024)
- Epigenetics of Prostate Cancer (Deadline: 31 August 2024)
- Advances in Bacteria and Cancer (Deadline: 10 September 2024)
- Unique Perspectives in Cancer Signaling (Deadline: 15 September 2024)
- Advances in Chronic Lymphocytic Leukemia Microenvironment: The Disruption of the Supportive Leukemic/Accessory Cells Interactions to Improve Therapy Response (Deadline: 15 September 2024)
- Lifestyle Choices and Endocrine Dysfunction on Cancer Onset and Risk (Deadline: 30 September 2024)
- Recent Updates on Cancer Stem Cells and Tumor Microenvironment (Deadline: 31 October 2024)
- New Molecular Targets and Emerging Approaches to Target Cancer Stem Cells (Deadline: 30 November 2024)
- Oral Cancer and the Microbiome (Deadline: 31 December 2024)
- State-of-the-Art Treatment on Chemotherapy and Immunotherapy for Urological Cancer (Deadline: 31 December 2024)
- Advances in Chronic Lymphocytic Leukaemia (CLL) Research (Deadline: 31 December 2024)
Topical Collections
Following topical collections within this section are currently open for submissions:
- Deciphering the Crosstalk between Tumor Cells and Their Microenvironment: From Molecular Aspects to Therapeutic Implications
- Kinases and Cancer
- Matrix Effectors and Cancer
- Molecular Signaling Pathways and Networks on Cancer
- New Discoveries and Future Trend for Prostate Cancer Research and Treatment
- Targeting Solid Tumors
